Delivery Order SPE2DR25D2205-SPE2DR26F2A90
Award Date 2/10/26
Potential Completion Date 2/11/26
Potential Value $6.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, with a ceiling value of $30,664.23 for supply of Vivitrol 380 mg vials and diluents.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 11, 2026 and is priced on a firm fixed-price basis. This delivery order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical.</p>
- The Defense Logistics Agency awarded a delivery order valued at $2,218.38 to Amerisourcebergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made on January 14, 2026, and represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $12,655.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Vivitrol 380 mg vial-diluents, with completion scheduled for December 12, 2025. This non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $6,655.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and completion scheduled for January 29, 2026. This is a firm fixed-price, non-set-aside contract awarded on a competitive basis. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for Vivitrol 380 mg vial-diluents with a ceiling value of $5,545.95.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 9, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a $6,200.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and completion targeted for February 3, 2026. This non-set-aside contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for $13,052.73 to supply Vivitrol 380 mg vial-diluents under firm fixed-price terms. The order is placed under the DLA Troop Support Medical IDC (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999 and running through December 2026. Place of performance is Conshohocken, PA. The ultimate completion date is February 11, 2026. No set-aside was used.
- The Defense Logistics Agency awarded a delivery order valued at $6,330.42 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This non-competitive delivery order, issued on November 24, 2025, represents a firm fixed-price transaction with an ultimate completion date of November 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through its corporate office location. This...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $3,327.57 for Vivitrol 380 mg vials with diluents, with an ultimate completion date of January 22, 2026. This is a firm fixed-price, non-set-aside contract awarded on January 21, 2026, with performance in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $31,860.95 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of February 2, 2026. This non-set-aside contract was awarded on a firm fixed-price basis and represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F2A90Delivery Order
The Defense Logistics Agency issued a $6,212.44 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Vivitrol 380 mg vial-diluents, with an ultimate completion date of February 11, 2026. Place of performance is Conshohocken, PA. The order was issued on a firm fixed-price basis with no set-aside. Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement needs through the Defense Logistics Agency's Troop Support Medical supply chain.
Generated 5/11/26, 11:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 2/9/26 |